Maihöfner C, Schlötzer-Schrehardt U, Gühring H, Zeilhofer H U, Naumann G O, Pahl A, Mardin C, Tamm E R, Brune K
Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Germany.
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2616-24.
Primary open-angle glaucoma (POAG) is the predominant form of chronic glaucoma, but the underlying pathologic mechanisms are largely unknown. Because prostaglandins (PGs) have been introduced into POAG treatment with remarkable success, this study was undertaken to investigate whether a change in the expression of the PG-synthesizing enzymes cyclooxygenase (COX)-1 and -2 might be involved in the pathogenesis of POAG.
Expression of COX-1 and -2 was assessed by confocal laser microscopy, immunohistochemistry, Western blot analysis, and real-time RT-PCR in human eyes with different forms of glaucoma (primary open-angle, angle-closure, congenital juvenile, and steroid-induced), as well as in age-matched control eyes. Additionally, PGE2 was measured in aqueous humor by means of an enzyme-linked immunoassay as a product of COX activity.
In normal eyes, ocular COX-1 and -2 expression were largely confined to the nonpigmented secretory epithelium of the ciliary body. By immunohistochemistry and real-time RT-PCR, COX-2 expression was completely lost in the nonpigmented secretory epithelium of the ciliary body of eyes with end-stage POAG, whereas COX-1 expression was unchanged. By immunohistochemistry, in the ciliary bodies of eyes in five patients with diagnosis of early POAG, eyes in two had complete loss of COX-2 expression and in three showed only a few remaining scattered COX-2-expressing cells. COX-2 expression in the ciliary body was also lost in patients with steroid-induced glaucoma and was reduced in patients receiving topical steroid treatment. Eyes of patients with either congenital juvenile or angle-closure glaucoma showed COX-2 expression indistinguishable from control eyes. Aqueous humor of eyes with POAG contained significantly less PGE2 than control eyes.
Both cyclooxygenase isoforms are constitutively expressed in the normal human eye. Specific loss of COX-2 expression in the nonpigmented secretory epithelium of the ciliary body appears to be linked to the occurrence of POAG and steroid-induced glaucoma.
原发性开角型青光眼(POAG)是慢性青光眼的主要类型,但其潜在的病理机制在很大程度上尚不清楚。由于前列腺素(PGs)已被成功应用于POAG治疗,因此本研究旨在探讨PG合成酶环氧合酶(COX)-1和-2表达的变化是否参与POAG的发病机制。
通过共聚焦激光显微镜、免疫组织化学、蛋白质印迹分析和实时逆转录聚合酶链反应(RT-PCR),评估不同类型青光眼(原发性开角型、闭角型、先天性青少年型和类固醇性)患者以及年龄匹配的对照者眼中COX-1和-2的表达。此外,通过酶联免疫吸附测定法检测房水中的前列腺素E2(PGE2),作为COX活性的产物。
在正常眼中,眼内COX-1和-2的表达主要局限于睫状体的无色素分泌上皮。通过免疫组织化学和实时RT-PCR检测,晚期POAG患者眼中睫状体无色素分泌上皮中的COX-2表达完全丧失,而COX-1表达未发生变化。免疫组织化学检测显示,在5例诊断为早期POAG的患者眼中,2例患者的睫状体中COX-2表达完全丧失,3例患者仅剩余少数散在的COX-2表达细胞。类固醇性青光眼患者的睫状体中COX-2表达也丧失,接受局部类固醇治疗的患者中COX-2表达降低。先天性青少年型或闭角型青光眼患者的眼中COX-2表达与对照者无差异。POAG患者眼中的房水PGE2含量明显低于对照者。
两种环氧合酶同工型在正常人眼中均有组成性表达。睫状体无色素分泌上皮中COX-2表达的特异性丧失似乎与POAG和类固醇性青光眼的发生有关。